News

Will International Stocks Outperform U.S. Markets This Year?

Will International Stocks Outperform U.S. Markets This Year?

Can International Stocks Surpass U.S. Performance?

According to recent insights from a Vanguard economist, the landscape for stock investments is shifting, suggesting that international markets might finally outpace U.S. stocks.

After facing challenges early in the year, U.S. stocks have rebounded impressively. The S&P 500 index has increased by approximately 16% year-to-date, while the Nasdaq Composite has seen an even more significant rise of about 21%. Also noteworthy is the Russell 3000 index, which has achieved a remarkable 15% gain.

However, while these figures are commendable, it's crucial to note that international stocks are leading the charge this year.

The FTSE Global All-Cap Ex US index has surged nearly 28% year-to-date, with leading indexes across Europe, Asia, and Emerging Markets also exhibiting strong performance. Specifically, the MSCI Europe index has climbed by 29%, the MSCI AC Asia Pacific index has increased by 28%, and the MSCI Emerging Markets index has posted an impressive 33% return.

This marks a significant turnaround from the trends observed over the past five to ten years, where U.S. stocks consistently outperformed their global counterparts.

Many investors are left contemplating whether this pattern of international outperformance indicates the beginning of a new trend or is simply a fleeting moment. Recently, Qian Wang, Vanguard’s chief economist for the Asia-Pacific region, shared her insights on the matter.

The short answer, according to her, is yes, but with some important considerations.

Are Valuations Indicating a Bubble in U.S. Stocks?

This year has brought about significant volatility for U.S. stocks, with various factors influencing this situation. However, the recovery since April has sparked concerns regarding potential overvaluations, particularly seen in the tech and AI sectors. Are we witnessing a bubble driven by AI hype?

“For several years, we have pointed out the increasing overvaluation of U.S. stocks. Yet, propelled by major tech firms, U.S. stocks have frequently reached new all-time highs. Unlike what occurred during the dot-com bubble over 25 years ago, we cannot categorically state that U.S. stocks are in a bubble,” Wang noted.

Wang highlighted that the leading tech firms are still generating substantial profits. Additionally, the prevailing environment that encourages innovation, coupled with relatively low regulation and robust corporate balance sheets, can rationalize the current high valuations, at least in the short term.

“Despite a more conservative outlook for long-term returns, the combination of economic growth, rising earnings, and the anticipated easing of Federal Reserve policies to mitigate risks creates an almost ideal scenario that could bolster U.S. market returns in the near future,” she stated.

Over the long haul, the story may change.

“Our findings indicate that over extended periods, typically around a decade or more, valuations tend to act as a gravitational force, ultimately leading returns to revert to historical averages,” Wang explained.

Valuations do not generally initiate market corrections but can increase vulnerability to shocks, meaning factors like renewed recession concerns, disappointing earnings, inflation spikes, slow Fed easing, geopolitical issues, or a decline in AI investments could heighten risks associated with already inflated valuations.

Rationale Behind U.S. Stocks Lagging International Equities

Vanguard economists predict that this reversion in valuations may inhibit the growth of U.S. stocks in the long term.

“Our analyses suggest that U.S. equities may lag behind non-U.S. stocks in the coming decade,” Wang indicated.

Nevertheless, she mentioned the possibility of U.S. stocks outperforming, largely due to the influence of AI technology.

“The transformative potential of AI is a significant boost to the U.S. market. If the full benefits of AI are realized, U.S. firms might sustain considerable growth,” Wang remarked.

However, she cautioned that international companies might gain even more from the widespread adoption and integration of AI into the broader economy.

“There is significant potential abroad, where AI and automation can significantly enhance productivity and efficiency, enabling international firms to catch up to their U.S. counterparts,” Wang stated. “Conversely, were AI to underperform, the decline of non-U.S. markets would likely be less severe than that of U.S. markets.”

Additionally, other influencing elements could favor international stocks, such as heightened defense expenditures and favorable policy modifications that could spur economic expansion. Currency fluctuations may pose less of a challenge for the U.S. market as investors increasingly diversify away from U.S. dollar assets.

Ultimately, Wang advocates for diversification in one's investment portfolio.

“Placing all investments into either U.S. or international markets is not advisable. Instead, investors should ensure a diversified approach, potentially leaning more towards international assets in the long run,” Wang advised.

Frequently Asked Questions

What are the current trends in U.S. and international stocks?

U.S. stocks have seen strong gains, but international stocks have outperformed them this year significantly.

What does Vanguard’s economist say about U.S. stocks?

Qian Wang suggests that while U.S. stocks have strong tech performance, they may be overvalued and could lag international stocks moving forward.

What role does AI play in stock performance?

AI is seen as a major tailwind for U.S. stocks but could benefit international companies even more in the long term.

Is it wise to invest solely in U.S. stocks?

Vanguard recommends diversifying investments to include international stocks for balanced growth.

What long-term projections does Vanguard make for U.S. equities?

Vanguard's analysis indicates that U.S. stocks might lag behind international stocks over the next decade.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 215

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 81

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Citi Confirms Positive Outlook for Nucor with $240 Target

Updated Category News Views 58

Nucor Corporation, a key player in the steel industry, had its Buy rating reaffirmed by Citi, setting a price target of $240. This was no idle gesture; it came hand-in-hand with a revised earnings per share (EPS) estimate dropped to $1.38 from an earlier forecast of $1.76, aligning closely with Nucor’s own guidance that projected an EPS between $1.30 and $1.40 for the...

Continue Reading
Investment Insights: Stanley Druckenmiller's Regional Bank Strategy

Updated Category News Views 288

Understanding Stanley Druckenmiller's Investment Approach Billionaire investor and former hedge fund manager Stanley Druckenmiller is well known for his unique approach to investing. With a knack for macroeconomic analysis, he consistently predicts market movements by taking a top-down view. A Bold Move into Regional Banks Recently, Druckenmiller made headlines with his...

Continue Reading
FFW Corporation Declares Latest Quarterly Dividend Payment

Updated Category News Views 192

FFW Corporation Announces Quarterly Cash Dividend WABASH, Ind. — FFW Corporation (OTC PINK: FFWC), the parent company of Crossroads Bank, has recently announced a quarterly cash dividend of $0.31 per share for its common stock. This dividend will be payable soon, specifically on September 26, and it targets shareholders who are recorded as of September 12. Financial...

Continue Reading
Alaris Equity Partners Secures Final Prospectus for New Offering

Updated Category News Views 101

Alaris Equity Partners Completes Final Prospectus Filing CALGARY, Alberta — Alaris Equity Partners Income Trust, known as Alaris, has made a significant move in its financial strategy by filing a final short form prospectus in various provinces across Canada. This filing aligns with their previously announced offering to secure $100 million in 6.25% convertible...

Continue Reading
Xtreme Fighting Championships Exciting Return to South America

Updated Category News Views 133

Xtreme Fighting Championships Exciting Return to South America Recently, Xtreme Fighting Championships (XFC), backed by Xtreme One Entertainment, Inc. (OTC: XONI), confirmed its much-anticipated return to the vibrant landscape of South America. This marks a significant milestone for the organization, which previously hosted numerous thrilling events in the region....

Continue Reading